Skip to main content
. 2018 Jun 20;21(2):182–189. doi: 10.4048/jbc.2018.21.2.182

Table 1. Distribution of study subjects in the intention-to-treat population.

Category No. (%)
Enrolled subjects 897 (100)
 Completed study 749 (83.5)
 Early dropouts 148 (16.5)
Reasons for dropouts
 Adverse events 45 (30.4)
 Abnormal laboratory tests 19 (12.9)
 Protocol violation 7 (4.7)
 Withdrawal of informed consent 18 (12.2)
 Follow-up loss 52 (35.1)
 Death 7 (4.7)